Lead sponsor
Peking University Third Hospital
3 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
3
Trials led
3
Active
1,352
Total enrollment
3
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
1
Not applicable
2
Trials by status
Not yet recruiting
2
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effects of GLP-1RAs on Reproductive Outcomes in PCOS and ObesityBMI ≤35not applicableNot yet recruiting392
A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis—not applicableNot yet recruiting70